Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Anika Therapeutics Inc.
Swot
Anika Therapeutics Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Anika Therapeutics Inc. has 6 Strengths, 19 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(6)
Weakness
(19)
Opportunity
(4)
Threats
(0)
Others
(1)
Best results last week in YoY net profit and revenue growth
Significant (over 30%) distance from 52 week high
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Stock with Low PE (PE < = 10)
Volume Shockers
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Weak Stocks (DVM)
High volume, top losers
Top Losers
Near 52 Week Low
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining Revenue every quarter for the past 2 quarters
RSI indicating price weakness
Near 52 Week Low
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
Promoters increasing shareholding QoQ
